Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT01892878
Other study ID # VGI-002
Secondary ID
Status Withdrawn
Phase N/A
First received July 1, 2013
Last updated March 14, 2018
Start date July 2013
Est. completion date January 1, 2016

Study information

Verified date July 2013
Source VG Innovations, LLC
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this clinical study is to evaluate fusion of the facet joints in a prospective cohort of patients utilizing the VerteLoc facet fixation device in patients receiving lumbar laminectomy (L1-S1), without ancillary stabilization devices such as pedicle and transfacet screws.


Description:

Study Design: Non-randomized, prospective, single arm clinical trial

Patient Population and Sample Size: Patients (n=25) from up to 2 clinical site, who have been medically evaluated, found appropriate for, and have agreed to treatment by lumbar decompressive laminectomy and facet fixation, including unilateral and/or bilateral posterolateral fusion according to accepted medical standards.

Objectives:

The primary objective of this study is to:

1. Evaluate the fusion status of facet joints following laminectomy and facet fixation using the VerteLoc system in combination with unilateral and/or bilateral posterolateral fusion.

2. Subject success / Clinical outcome: Evaluate the reduction in baseline VAS back pain score at 2-3 weeks, 3 months, and 12 months.

The secondary objectives of this study are to:

1. Explore the effect of preoperative bone density on facet fusion status;

2. Assess the ease of use of the VerteLoc system;

3. Record operative time using the VerteLoc system;

4. Monitor the occurrence of adverse events related or possibly related to the use of the VerteLoc system;

5. Monitor the occurrence of subsequent surgical intervention at the target level(s).

6. Subject success/Clinical outcome (Assess additional improvement criteria)

7. Evaluate Fusion rate in relations to DEXA value

Inclusion Criteria: Candidates must meet ALL of the following:

1. Have provided consent for research by signing the Institutional Review Board approved Informed Consent;

2. Have given appropriate operative consent for a decompressive lumbar (L1-S1) laminectomy procedure as standard of care;

3. Are skeletally mature, and are at least 18 years of age;

4. If female, are not pregnant;

5. Agree to adhere to post-surgical medically prescribed activity limitations and/or physical rehabilitation.

Exclusion Criteria:

1. Previous surgery at the target or adjacent vertebral levels;

2. More than two intervertebral levels to be treated by the laminectomy procedure;

3. Found to be inappropriate candidates for facet fixation using the VerteLoc system;

4. Require additional and/or other surgical technique and/or approach to the laminectomy at the index level(s), which may in the opinion of the Primary Investigator confound measurement of outcome variables;

5. Has a medical disorder or is receiving medications that would be expected to interfere with osteogeneses,

6. Active malignancy or patient with a history of any malignancy (except non-melanoma skin cancer) with recurrence within 5 years of surgery;

7. Active local or systemic infection or history of local or systemic infection, immune-deficiency, uncontrolled medical conditions, which in the opinion of the Investigator may increase patient risk or confound fusion results;

8. BMI >40% ;

9. History of tobacco smoking within the past 6 months;

10. Has a history of alcoholism, medication or drug abuse, psychosis, is a prisoner, and/or has a personality disorder, poor motivation, emotional or intellectual issues that would likely make the patient unreliable for participation in the study;

11. Are participating in any other clinical trial. Study Duration : 12 months

Study Outcomes:

The primary study outcomes of this study are:

1. Fusion grade at 12 month follow-up using CT scans with a grading system based on:

1. Complete fusion;

2. Partial fusion;

3. No fusion;

2. Subject success / Clinical outcome:

Evaluate the reduction in baseline VAS back pain score at:

1. 2-3 weeks

2. 3 months

3. 12 months.

The secondary outcomes of this study are:

1. Statistical correlation of DEXA scan bone mass density score to CT and radiographic fusion status;

2. Surgeon opinion of "ease of use" utilizing the VerteLoc system (0-10);

3. Operative time (minutes) from surgical access to completion of device placement

4. Occurrence and prevalence of adverse events related or possibly related to the use of the VerteLoc System;

5. Occurrence of subsequent surgical intervention at the target level(s).

Study Assessments

- Intraoperative: Post-placement radiograph;

- 12 months: A/P and lateral flexion and extension lumbar radiograph and lumbar CT scan.

Statistical Analysis

• Student t-tests


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date January 1, 2016
Est. primary completion date July 2015
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

1. Have provided consent for research by signing the Institutional Review Board approved Informed Consent;

2. Have given appropriate operative consent for a decompressive lumbar (L1-S1) laminectomy procedure as standard of care;

3. Are skeletally mature, and are at least 18 years of age;

4. If female, are not pregnant;

5. Agree to adhere to post-surgical medically prescribed activity limitations and/or physical rehabilitation.

Exclusion Criteria:

1. Previous surgery at the target or adjacent vertebral levels;

2. More than two intervertebral levels to be treated by the laminectomy procedure;

3. Found to be inappropriate candidates for facet fixation using the VerteLoc system;

4. Require additional and/or other surgical technique and/or approach to the laminectomy at the index level(s), which may in the opinion of the Primary Investigator confound measurement of outcome variables;

5. Has a medical disorder or is receiving medications that would be expected to interfere with osteogeneses,

6. Active malignancy or patient with a history of any malignancy (except non-melanoma skin cancer) with recurrence within 5 years of surgery;

7. Active local or systemic infection or history of local or systemic infection, immune-deficiency, uncontrolled medical conditions, which in the opinion of the Investigator may increase patient risk or confound fusion results;

8. BMI >40% ;

9. History of tobacco smoking within the past 6 months;

10. Has a history of alcoholism, medication or drug abuse, psychosis, is a prisoner, and/or has a personality disorder, poor motivation, emotional or intellectual issues that would likely make the patient unreliable for participation in the study;

11. Are participating in any other clinical trial.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
VerteLoc
Single Arm

Locations

Country Name City State
United States Genesys Regional Medical Center Grand Blanc Michigan

Sponsors (1)

Lead Sponsor Collaborator
VG Innovations, LLC

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Fusion grade at 12 month follow-up using CT scans Fusion grade at 12 month follow-up using CT scans with a grading system based on:
Complete fusion;
Partial fusion;
No fusion;
12 months
Secondary Subject success / Clinical outcome Subject success / Clinical outcome:
Evaluate the reduction in baseline VAS back pain score.
2-3 weeks, 3 months and 12 months
See also
  Status Clinical Trial Phase
Completed NCT06290908 - RPE-P/TLIF for Lumbar Spinal Stenosis With Instability
Withdrawn NCT03223701 - Efficacy of Using Solum IV and BMC With GFC in TLIF Phase 4
Recruiting NCT03883022 - Vancomycin Powder Combined With Autogenous Bone Graft as a Prevention for Post-operative Infection for Spine Surgery N/A
Completed NCT02902380 - The Effect of Dexmedetomidine on Neuroendocrine Stress Hormone Release and Heart Rate Variability in Patients Undergoing Major Spinal Surgery N/A
Not yet recruiting NCT06024785 - Vertebropexy - Randomized-controlled Trial N/A
Not yet recruiting NCT06000319 - Natural Matrix Protein™ (NMP™) Fibers in Cervical and Lumbar Interbody Fusion
Completed NCT02558621 - New Robotic Assistance System for Spinal Fusion Surgery N/A
Completed NCT02454400 - Pre-surgery Physiotherapy for Patients With Specific Low Back Pain N/A
Completed NCT01377623 - Pilot Study on the Effect of Dexmedetomidine on Inflammatory Responses in Patients Undergoing Lumbar Spinal Fusion N/A
Terminated NCT00974623 - Bone Graft Materials Observational Registry N/A
Completed NCT00996073 - Safety and Preliminary Efficacy Study of NeoFuse in Subjects Requiring Lumbar Interbody Fusion Phase 2
Completed NCT00320619 - Epsilon-Aminocaproaic Acid to Reduce the Need for Blood Transfusions During and Following Spine Surgery N/A
Completed NCT00022776 - Surgical Versus Nonsurgical Treatment for Spinal Stenosis Phase 3
Completed NCT06060821 - Validity and Reliability of the 2-minute Step Test in Patients With Lumbar Spinal Stenosis
Recruiting NCT04552145 - Physical Therapy vs Surgical Decompression for Lumbar Spinal Stenosis N/A
Active, not recruiting NCT04379921 - Improving Spine Surgical Care With Real-Time Objective Patient Tracking Using the Apple Watch N/A
Withdrawn NCT04315090 - Post-surgical Outcomes Measure Using the ERAS Protocol for Posterior Cervical Decompression and Fusion
Completed NCT04591249 - Physical Activity Intervention for Patients Following Lumbar Spine Surgery N/A
Recruiting NCT04601363 - Personalized Spine Study Group (PSSG) Registry
Completed NCT04193488 - Mid-Transverse Process to Pleural (MTP) Block and Erector Spinal Plan (ESP) Block in Spinal Surgery N/A